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Abstract

Introduction

The lack of purine salvage enzyme, adenine phosphoribosyltransferase (APRT), leads to 2,8-dihydroxyadenine stone formation and/or crystalluria because it is
insoluble in urine. Urolithiasis composed of 2,8-dihydroxyadenine is not only formed in a complete defect of
APRT, but also in a partial deficiency of this enzyme.
The defect is inherited as an autosomal recessive trait,
the homozygous state is associated with high urinary
levels of 2,8-dihydroxyadenine
and with crystalluria,
calculus formation, and potential nephrotoxicity. Determination of the APRT activity will facilitate quantification of the enzyme deficiency and elucidation of the hereditary history. 2, 8-dihydroxyadenine excretion in the
24-hour urine and its circadian rhythm were determined
using a new method of high performance liquid chromatography determination. By means of a standard case
presentation, we illustrate the analysis of urinary sediments and calculi as well as the scanning electron microscopic images of this kind of stone.

In 1968, Kelly et al. described a formerly unknown disorder in purine metabolism caused by a deficiency of the enzyme adenine phosphoribosyltransferase
(APRT) [8]. This defect is inherited as an autosomal
recessive trait [l, 7).
The complete or partial lack of the salvage enzyme obstructs the conversion of adenine to adenosine
monophosphate. The alternative metabolic route available for urinary excretion is the oxydation of the increased concentration of adenine to 8-hydroxyadenine
(Fig. 1). The inadequate solubility of 2,8-dihydroxyadenine (2,8-DHA) in the normal pH-range of human
urine (namely 4.8-8.0) leads to crystalluria and stone
formation [ 12]. Homozygotes tend to develop urinary
calculi in early childhood. As stone formation in children does not occur frequently, the possibility of 2,8DHA stones should come to mind when X-ray negative
stones are found in children [I, 6, 7, 13). 2,8-DHA
urolithiasis in homozygotes was first described in 1974
[2]. Since that time, 20 cases have been described in
medical literature [9]. By means of a standard case
presentation, we illustrate here the analysis of 2,8-DHA
urinary sediments and calculi as well as the scanning
electron microscopic (SEM) appearance of this kind of
stone [11].
Materials and Methods
A 30-year-old male patient, who had produced Xray negative calculi in his left kidney since infancy, lost
the kidney at 8 years of age (no stone analysis). At the
age of 22, first spontaneous excretion of stones from the
remaining right kidney was observed. The first stone
analysis by infrared (IR) spectroscopy was made after a
further 3 years and showed 2,8-DHA. In 1987, 8 concrements in the right kidney were sonographically detected. The majority of the stones were removed percutaneously.
The remaining concrements were passed
spontaneously. The stone analysis by IR spectroscopy
revealed also 2,8-DHA.
There was no known family
history of lithiasis.
Laboratory Investigations
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Figure 1. Diagram of purine metabolism. XO = xanthine oxidase, APRT = adenine phosphoribosyltransferase, HGPRT = Hypoxanthineguaninephosphoribosyltransferase, IMP = Inosinemonophosphat, AMP = Adeninemonophospat.
Figure 4. Infrared spectra of a 2,8-DHA (a) and uric
acid (b). At wavelengths 3045, 3238 and 3338 cm- 1,
there are characteristic absorptions which do not occur
in uric acid.
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Figure 2. Microscopic examination of the crystalline
urinary sediment containing 2,8-dihydroxyadeninuria
spherical crystals in a radial corona. Bar = ??? µm.
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Figure 5. 2,8-DHA concentration in urine with (solid
line) and without 3 x 100 mg allopurinol treatment
(dotted line).
the crystalline urinary sediment was made after centrifugation. A large quantity of crystalline material was obtained for quantitative IR analysis. IR spectroscopic
concrement analysis of the urinary sediment and the
stone was performed using the KBr press process [14].

APRT activity: The activity of the enzyme was
assayed in the erythrocyte hemolysat by a radiochemical
technique [3]. Quantitative 2,8-DHA determination in
the urine was performed using high performance liquid
chromatography (HPLC) in conj unction with a separating system specially developed for purine [4].
SEM investigations: In order to study the morphology of the concrements, their surfaces, stone interspaces, fracture surfaces, and a commercially available
synthetic test substance of 2,8-DHA were examined by
scanning electron microscopy (SEM).

Figure 3. Scanning electron micrograph of 2,8-dihydroxyadenine stone crystals in urinary sediment. Bar =
10 µm.
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Results

Discussion

In the presence of APRT deficiency, and dependent upon the scale of the enzyme deficiency, crystals
were detected in the urine. Masses of crystals were always present; they were spherical in shape and brownred in color. Under a light microscope, the crystalline
arrangement was spherolitic (Figure 2).
Under the
SEM, nests of individual crystals were detected, some
10 µm in diameter, which also aggregated to form
microliths (Figure 3).

Only the introduction of new methods of urinary
stone analysis such as X-ray diffraction and IR spectroscopy have made it possible to identify 2,8-DHA calculi.
There is no structural difference between 2,8-DHA and
uric acid. Since there is still no way to heal this "inborn error of metabolism", recurrence of stone formation can only be prevented by strict life-long treatment.
The SEM has been instrumental in yielding valuable new data in the field of stone research. The variety
of microscopic forms and the different structures of
urine stones can be observed in details with the SEM.
Whereas examinations have been carried out with the
SEM on most types of urinary stones, an analysis of the
2,8-DHA stone, due to its extreme rarity, was lacking.
This paper presents SEM analysis of the test substance
after recrystallization, urinary sediment, stone surface,
stone interfaces, and fracture surface of the 2,8-DHA
stone. Once a 2,8-DHA stone has been diagnosed, the
enzyme deficiency can be determined by measuring
APRT activity in erythrocyte haemolysate. Making use
of this relatively simple test, a possible hereditary factor
may be determined in other family members.
The HPLC method permits a quantitative determination of 2,8-DHA excretion in urine. With this method, the monitoring of treatment is easy and reliable. In
addition to allopurinol therapy, the dilution of urine
throughout the day, sufficient fluid intake, and a lowpurine diet are advised to eliminate 2,8-DHA excretion
in urine.

2,8-DHA can only be detected using modern
chemophysical methods of analysis [5, I 0]. The chemical method will always produce a false result indicating
uric acid.
Infra-red spectroscopic analysis indicated
that both urinary sediments and stones consisted of pure
2, 8-dihydroxyadenine.
The characteristic absorptions
observed at wavelengths 3045, 3238 and 3338 cm- 1 do
not occur in any other type of urolith, e.g., uric acid
(Figures 4a, 4b).
In order to obtain a clear picture of the extent of
the enzyme deficiency, the lack of APRT activity in
haemolysed erythrocytes must be determined. Caution
is advisable if the patient has just received blood transfusions, which can lead to a temporary increase in
APRT activity.
The determination of 2,8-DHA in urine was carried out by the HPLC method. In the 24-hour urines of
healthy test persons, no "-,8-DHA could be traced. If
2,8-DHA is found, it can always be regarded as an indicator of APRT deficiency.
2,8-DHA excretion rates in our patient ranged between 125 and 160 µmol/1 (i.e., 245-414 µmol per 24
hours). Treatment with 300 mg allopurinol per day reduced the daily excretion to 40 µmol/day. The excretion of 2,8-DHA shows a characteristic
day/night
rhythm. Increased rates were registered at night and in
the morning hours. The administration of the xanthinoxydase inhibitor allopurinol reduced excretion rates to a
constantly low level, while adenine concentration in
urine increased (Figure 5).
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SEM examination of the synthetic test material
after fast recrystallization
revealed plaque-shaped
structures (Figure 6), and after slow recrystallization
spherical, matted structures (Figure 7).
With increasing magnification,
the 2,8-DHA
stone shows a spherical surface, a felt-like surface and
spherolite surface with matted needle-shaped crystals
(Figures 8, 9, 10 and 11). The SEM examination of
structures in stone interspaces revealed mostly needleshaped crystals (Figure 12), although, sometimes lanceshaped crystals were also observed (Figure 13). After
fragmentation of a 2,8-DHA stone and SEM examination
of individual fragments, microliths with an irregular
surface, and sometimes a fracture surface with peripheral regular crystals, were observed (Figures 14, 15, 16
and 17).
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Figure 6. Synthetic test material.

Plaque-shaped structure.

Figure 7. Synthetic test material.

Spherical, matted structure.

Figure 8. Spherical surface.
Figure 9.
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Slow crystallisation.
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Spherical, now felt-like surface.

Bar = 100 µm.

Figure 10. Spherolite surface with matted needle-shaped crystals.
Figure 11. Similar structures with regular crystals.
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Figure 12. Needle-shaped crystals.
Figure 13. Lance-shaped crystals.
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Figure 14. Microlith with irregular surface.

Bar

= 10

µm.

Figure 15. Doubled magnification shows a similar surface structure.
Figure 16. Fracture surface of a 2,8-DHA stone.
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Figure 17. Fracture surface with peripheral regular crystals.
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cannot be achieved through oral medication.
In any
case, attempts to change the pH-value by means of percutaneous chemolitholysis will fail because of incompatible tissue tolerance; even if this problem was irrelevant, the many potential side effects of this kind of
therapy would forbid its application.

Discussion with Reviewers

A. Rogers: How sensitive are your IR measurements?
Authors: The sensitivity of IR spectroscopic measurements is dependent on the composition of substances investigated. All components exceeding 5 % can be unmistakably determined.

S.R. Khan: What are the some of the other features
associated with this disease?
Authors: Other features associated with APRT-deficiency on its own are not known. APRT-deficiency,
when not treated, may lead to nephrocalcinosis with
resultant renal failure.
A. Rogers: In the Materials and Methods section, you
mention that the first stone analysis showed 2,8-DHA.
What technique was used for this analysis?
Authors: We used infrared spectroscopy.
A. Rogers: Do you think that the brown red colour of
the 2,8-DHA crystals is due to blood stains? Uric acid
microliths are often red orange. Were the 2,8-DHA
crystals similar in colour to uric acid crystals?
Authors: 2,8-DHA crystals of brown-red colour appeared in several patients and cannot be attributed to
blood stains in our opinion. It is most likely that urine
colouring matter may be adsorbed by 2,8-DHA, which
causes this kind of stone to appear very similar to a uric
acid stone.
A. Rogers: Figures 11, 12 and 13 show crystals which
are very similar to the morphological features of sodium
urate. Were no other stone components besides 2,8DHA detected (e.g., uric acid and salts thereof)?
Authors: Analyses by IR proved 2,8-DHA stones to be
extremely pure.
Components of uric acid or salts
thereof are rather unlikely.

H. Iwata: Was dissolution carried out by heating or
changing pH? Was the substance dissolved in pure
water, buffer solution, and urine?
Authors: 2,8-DHA was obtained from Sigma (Article
no. D7382). The substance was heated in pure water at
neutral pH at 80°C.
After filtration, one part was
cooled down to room temperature (slow crystallization),
and the other part in ice water (fast crystallization).

A. Rogers: Did you consider verifying your results by
subjecting the crystals to another analytical technique
such as as X-ray powder diffraction or mass spectrometry?
Authors: Results achieved through IR spectroscopy
were confirmed
by X-ray diffraction.
Mass
spectroscopy was not applied.

D.B. Leusmann: Is there a possibility to resolve 2,8DHA stones either by oral medication (similar to uric
acid stones) or by direct dissolution after pyelostomy
and/or indwelling ureteral stents?
Authors: The dissolution of 2,8-DHA stones by oral
medication is not possible.
Solubility of 2,8-DHA
stones in the pH-range of 4.8-8.0 varies between 3 and
5 mg/I. A considerable increase in solubility can be
achieved at a pH-range less than 2 or more than 9. 5;
however, such extensive changes in human pH-values

Editor: Am I correct in understanding that Figures 8 to
17 are from different stones collected from your 30 year
old patient?
Authors: Yes; Figures 6 and 7 are scanning electron
micrographs from synthetic crystals; while Figures 8 to
17 are from stones collected from the patient.
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